Pill known as OXO-001, designed to act directly on womb lining, could improve rate of embryo implantation
A trial of a new fertility drug has shown that it could improve the rate of embryo implantation during IVF and lead to a 7% increase in live births.
The pill, known as OXO-001, is designed to act directly on the lining of the womb to make it more receptive to the embryo being implanted. The findings raise hope for patients who have experienced repeated implantation failures during successive rounds of IVF.
About Author
More Stories
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Bizarre Australian mole even more unusual than first thought, new research reveals